北京亚太肝病诊疗技术联盟
北京亚太肝病诊疗技术联盟欢迎您!!!   北京亚太肝病诊疗技术联盟欢迎您!!!

  >>   杂志期刊
北京亚太肝病诊疗技术联盟
电话:010-53383907
邮箱:fanyatongze516@163.com
网址:www.apald.org
地址:东园文化创意广场F座2层216

    当前位置  >>  首页  >> 杂志期刊
 
益生菌对轻微肝性脑病疗效的Meta分析
 发布时间:2022/7/16 浏览次数:392

益生菌对轻微肝性脑病疗效的Meta分析
作者:蒲新霖1  蒋昭友2 
单位:1.成都市第七人民医院 消化内科 成都 610044 2.成都市第七人民医院 肿瘤科 成都 610044 
关键词:益生菌 轻微肝性脑病 Meta分析 随机对照试验 
分类号:
出版年,卷(期):页码:2022,14(1):19-26
摘要:
摘要:目的 系统评价益生菌治疗轻微肝性脑病(minimal hepatic encephalopathy, MHE)的有效性。方法 计算机检索PubMed、EMbase、Cochrane Central Register of Controlled Trials、中国知网、万方、中国生物医学文献数据库和维普数据库,检索益 生菌制剂治疗MHE的随机对照试验(randomized controlled trial,RCT),检索时限 均为建库至2020年7月26日。检索美国临床试验注册平台(ClinicalTrials.gov)进行文 献补充。由2名研究人员独立筛选文献、提取数据、评价纳入研究的偏倚风险,采用 RevMan 5.3进行Meta分析。结果 共纳入13篇RCT,Meta分析表明益生菌治疗组在降低 血氨水平(SMD = -0.79,95%CI:-1.20~-0.37,P = 0.0002)、缩短数字连接试验-A型 (number connection test-type A,NCT-A)反应时间(MD = -16.31,95%CI:-22.09~ -10.53,P < 0.001)、降低显性肝性脑病发生率(RR = -0.26,95%CI:0.12~0.56, P = 0.0007)、提高MHE逆转率(RR = 1.48,95%CI:1.11~1.97,P = 0.008)和提高 数字符号试验(digit symbol test,DST)分数(SMD = 0.61,95%CI:0.35~0.86,P < 0.001)方面均显著优于对照组。益生菌治疗组与对照组的内毒素水平(SMD = -0.58, 95%CI:-2.29~1.13,P = 0.51)和丙氨酸氨基转移酶水平(MD = -36.18,95%CI: -86.65~14.29,P = 0.16)差异均无统计学意义。结论 益生菌可改善MHE患者认知功 能,提高MHE逆转率,降低显性肝性脑病发生率,有望成为临床治疗MHE的新选择。
Abstract: Objective To systematically evaluate the effects of probiotics in treatment of minimal hepatic encephalopathy (MHE). Methods PubMed, EMbase, The Cochrane Central Register of Controlled Trials, CNKI, Wanfang, CBM and Viper databases were electronically searched to collect randomized controlled trial (RCT) of the treatment of MHE by probiotics from inception to July 26th, 2020. US clinical trial registration platform (ClinicalTrials.gov) was also searched for supplementary literature. Two reviewers screened literature, extracted data and assessed the risk of bias of included studies independently. Meta-analysis was performed by RevMan 5.3 software. Results A total of 13 RCT were included. The results of Meta-analysis indicated that probiotics treatment group was superior to control group on blood ammonia level (SMD = -0.79, 95%CI: -1.20~-0.37, P = 0.0002), time of number connection test-type A (NCT-A) (MD = -16.31, 95%CI: -22.09~-10.53, P < 0.001), incidence of overt hepatic encephalopathy (RR = -0.26, 95%CI: 0.12~0.56, P = 0.0007), reversal rate of MHE (RR = 1.48, 95%CI: 1.11~1.97, P = 0.008) and score of digital symbol test (DST) (SMD = 0.61, 95%CI: 0.35~0.86, P < 0.001). There were no significant differences in endotoxin level (SMD = -0.58, 95%CI: -2.29~1.13, P = 0.51) and the alanine transaminase (ALT) level (MD = -36.18, 95%CI: -86.65~14.29, P = 0.16) of patients between two groups. Conclusions Probiotics can improve cognitive function of patients with MHE, increase the reversal rate of MHE and reduce the incidence of overt hepatic encephalopathy, which may become a new measure of clinical treatment in future.
基金项目:
作者简介:
参考文献:
服务与反馈:
文章下载】【加入收藏
 
北京亚太肝病诊疗技术联盟
电话:010-53383907
邮箱:fanyatongze516@163.com
网址:www.apald.org
地址:东园文化创意广场F座2层216
Copyright © 2004-2014  北京亚太肝病诊疗技术联盟    备案号:京ICP备15029603号-1